Woerner
06-29-2004, 07:17 AM
The State of Rhode Island is carefully weighing that question as they seek to save money on imported drugs. Critics say the state will end up losing money because investors will shy away from such programs.
"The investment community has said over and over, why would they take the risk in a state that is not friendly to biotechnology?”
"is that we may end up with the worst of all worlds: We would have the stigma of being perceived as anti-biotech without actually having ultimately the benefit of lower drug costs for our citizens."
To read more go to: http://www.zwire.com/site/news.cfm?BRD=1712&dept_id=24361&newsid=12134628&PAG=461&rfi=9
"The investment community has said over and over, why would they take the risk in a state that is not friendly to biotechnology?”
"is that we may end up with the worst of all worlds: We would have the stigma of being perceived as anti-biotech without actually having ultimately the benefit of lower drug costs for our citizens."
To read more go to: http://www.zwire.com/site/news.cfm?BRD=1712&dept_id=24361&newsid=12134628&PAG=461&rfi=9